A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

This study is currently recruiting participants.

Verified January 2012 by Astellas Pharma Inc

Sponsor:

Collaborator:

Astellas Pharma Korea, Inc.

Information provided by (Responsible Party):

Astellas Pharma Inc

ClinicalTrials.gov Identifier:

NCT01505439

First received: January 4, 2012

Last updated: NA

Last verified: January 2012

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2012
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)